Carvedilol Post-intervention Long-term Administration in Large-scale Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 801 participants.

Also called NCT01155635

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 801 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01155635
Other papers using this trial's data
  • Effects of Long-Term Carvedilol Therapy in Patients With ST-Segment Elevation Myocardial Infarction and Mildly Reduced Left Ventricular Ejection Fraction The American journal of cardiology, 2023-07-15 DOI, PubMed 37245250
  • Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention PloS one, 2018 DOI, PubMed 30153268, PMC6112626 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01155635. Randomized; single masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2015-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Carvedilol Post-intervention Long-term Administration in Large-scale Trial
Acronym
CAPITAL-RCT
Intervention (Drug)
Carvedilol
Intervention (Drug)
No Carvedilol
Lead sponsor
Takeshi Morimoto (class: other)

Record details

Record id
cardio:ct-nct01155635
Content hash
0cc2123482c2f9d52b32315ed30b310d9443d804e1f38798dd3504512b5e1aa5